The effects of apixaban in reducing stroke, mortality, and bleeding were consistent irrespective of GDF-15 levels, but no data is shown if apixaban had any influence on the levels of GDF-15 to mitigate inflammation. The gene discussed is GDF15; the disease is Stroke.